Physical activity and exercise have the potential to prevent and mitigate cerebral small vessel disease-related brain damage and improve cognitive function.
Does physical activity and exercise prevent or mitigate brain damage and improve cognitive function in patients with cerebral small vessel disease?
Exercise represents a promising non-pharmacological strategy to prevent and mitigate cerebral small vessel disease and associated cognitive impairment, with a need for further research into specific exercise modalities like resistance training.
Vascular contributions to cognitive impairment and dementia, specifically cerebral small vessel disease (CSVD), are the second most common cause of dementia. Currently, there are no specific pharmacological treatments for CSVD, and the use of conventional antidementia drugs is not recommended. Exercise has the potential to prevent and mitigate CSVD-related brain damage and improve cognitive function. Mechanistic pathways underlying the neurocognitive benefits of exercise include the control of vascular risk factors, improving endothelial function, and upregulating exerkines. Notably, the therapeutic efficacy of exercise may vary by exercise type (ie, aerobic versus resistance training) and biological sex; thus, studies designed specifically to examine these moderating factors within a CSVD context are needed. Furthermore, future research should prioritize resistance training interventions, given their tremendous therapeutic potential. Addressing these knowledge gaps will help us refine exercise recommendations to maximize their therapeutic impact in the prevention and mitigation of CSVD.
Dao et al. (Tue,) conducted a review in Cerebral small vessel disease (CSVD). Physical activity and exercise was evaluated. Physical activity and exercise have the potential to prevent and mitigate cerebral small vessel disease-related brain damage and improve cognitive function.